Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide

Podobne zapisy

• Gender differences in safety issues during Fingolimod therapy: Evidence from a real‐life Relapsing Multiple Sclerosis cohort
  od: Manni, Alessia, i wsp.
  Wydane: (2017)
• Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
  od: Tommaso Guerra, i wsp.
  Wydane: (2025-03-01)
• Both a Protective and a Deleterious Role for the L76V Mutation
  od: Tartaglia, Alessandra, i wsp.
  Wydane: (2009)
• Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
  od: Bollo, Luca, i wsp.
  Wydane: (2021)
• Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study
  od: Bavaro, Davide Fiore, i wsp.
  Wydane: (2021)